Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Gross Margin: 2018-2024

Historic Gross Margin for Sunshine Biopharma (SBFM) over the last 7 years, with Dec 2024 value amounting to 30.60%.

  • Sunshine Biopharma's Gross Margin fell 134.00% to 32.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.01%, marking a year-over-year increase of 223.00%. This contributed to the annual value of 30.60% for FY2024, which is 402.00% down from last year.
  • As of FY2024, Sunshine Biopharma's Gross Margin stood at 30.60%, which was down 11.61% from 34.61% recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Gross Margin peaked at 63.80% during FY2020, and registered a low of 30.60% during FY2024.
  • In the last 3 years, Sunshine Biopharma's Gross Margin had a median value of 34.61% in 2023 and averaged 34.75%.
  • Per our database at Business Quant, Sunshine Biopharma's Gross Margin soared by 1,612bps in 2020 and then tumbled by 1,539bps in 2021.
  • Sunshine Biopharma's Gross Margin (Yearly) stood at 63.80% in 2020, then slumped by 1,539bps to 48.42% in 2021, then tumbled by 938bps to 39.04% in 2022, then slumped by 443bps to 34.61% in 2023, then crashed by 402bps to 30.60% in 2024.